France· FR:66271123
ZELBORAF 240 mg, comprimé pelliculé
A medicinal product containing vémurafénib, registered in France by ROCHE REGISTRATION (ALLEMAGNE), on the national reimbursement list.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- VÉMURAFÉNIB
- Manufacturer
- ROCHE REGISTRATION (ALLEMAGNE)
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- cip13340092208756656 plaquette(s) thermoformée(s) aluminium de 1 comprimé(s)EUR 1.29
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Vémurafénib in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandZelborafOrifarm Oy
- United StatesZELBORAFGenentech, Inc.
- SpainZELBORAF 240 mg COMPRIMIDOS RECUBIERTOS CON PELICULARoche Registration Gmbh
- IrelandZelboraf 240 mg film-coated tabletsRoche Registration GmbH
- BelgiumZelboraf 240 mgRoche Registration
- NetherlandsZelboraf 240 mg, filmomhulde tablettenRoche Registration GmbH
- NorwayZelborafRoche Registration GmbH
- PolandZelborafRoche Registration GmbH
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Zelboraf
- Liechtenstein · Zelboraf
- Norway · Zelboraf
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/5be54876-9e49-4e04-aa9c-af2fd491c7d3 GET /v1/drugs/5be54876-9e49-4e04-aa9c-af2fd491c7d3?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "66271123",
"date_amm": "2012-02-17",
"type_amm": "Procédure centralisée",
"numero_ue": "EU/1/12/751",
"substance": "VÉMURAFÉNIB",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "comprimé pelliculé",
"voies_administration": "orale",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about vémurafénib.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.